Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 17 Similar Profiles
Systemic Lupus Erythematosus Medicine & Life Sciences
Pregnancy Medicine & Life Sciences
Kidney Medicine & Life Sciences
Lupus Nephritis Medicine & Life Sciences
African Americans Medicine & Life Sciences
Antiphospholipid Syndrome Medicine & Life Sciences
Antiphospholipid Antibodies Medicine & Life Sciences
Autoantibodies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1985 2017

Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod

Petri, M. A., Martin, R. S., Scheinberg, M. A. & Furie, R. A. Jan 1 2017 In : Lupus. 26, 1, p. 27-37 11 p.

Research output: Contribution to journalArticle

Systemic Lupus Erythematosus
Fatigue
Clinical Trials
Chronic Disease
Placebos

Disease activity patterns over time in patients with SLE: Analysis of the Hopkins Lupus Cohort

Györi, N., Giannakou, I., Chatzidionysiou, K., Magder, L., Van Vollenhoven, R. F. & Petri, M. Jan 1 2017 In : Lupus Science and Medicine. 4, 1, e000192

Research output: Contribution to journalArticle

Physicians

Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: A phase II dose-ranging randomised controlled trial

Wallace, D. J., Strand, V., Merrill, J. T., Popa, S., Spindler, A. J., Eimon, A., Petri, M., Smolen, J. S., Wajdula, J., Christensen, J., Li, C., Diehl, A., Vincent, M. S., Beebe, J., Healey, P. & Sridharan, S. Mar 1 2017 In : Annals of the Rheumatic Diseases. 76, 3, p. 534-542 9 p.

Research output: Contribution to journalArticle

Systemic Lupus Erythematosus
Interleukin-6
Monoclonal Antibodies
Placebos
Safety

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

Pickrell, P. & 296 others Clowse, M. E. B., Wallace, D. J., Furie, R. A., Petri, M. A., Pike, M. C., Leszczyński, P., Neuwelt, C. M., Hobbs, K., Keiserman, M., Duca, L., Kalunian, K. C., Galateanu, C., Bongardt, S., Stach, C., Beaudot, C., Kilgallen, B., Gordon, C., Batalov, A., Bojinca, M., Djerassi, R., Duca, L., Horak, P., Kolarov, Z., Milasiene, R., Monova, D., Otsa, K., Pileckyte, M., Popova, T., Radulescu, F., Rashkov, R., Rednic, S., Repin, M., Stoilov, R., Tegzova, D., Vezikova, N., Vitek, P., Zainea, C., East, F., Baek, H., Chen, Y., Chiu, Y., Cho, C., Chou, C., Choe, J., Huang, C., Kang, Y., Kang, S., Lai, N., Lee, S., Park, W., Shim, S., Suh, C., Yoo, W., Armengol, H. A., Zapata, F. A., Santiago, M. B., Cavalcanti, F., Chahade, W., Costallat, L., Keiserman, M., Alcala, J. O., Remus, C. R., Roimicher, L., Abu-Shakra, M., Agarwal, V., Agmon-Levin, N., Kadel, J., Levy, Y., Mevorach, D., Paran, D., Reitblat, T., Rosner, I., Shobha, V., Sthoeger, Z., Zisman, D., Ayesu, K., Berney, S., Box, J., Busch, H., Buyon, J., Carter, J., Chi, J., Clowse, M., Collins, R., Dao, K., Diab, I., Dikranian, A., El-Shahawy, M., Gaylis, N., Grossman, J., Halpert, E., Huff, J., Jarjour, W., Kao, A., Katz, R., Kennedy, A., Khan, M., Kivitz, A., Kohen, M., Lawrence-Ford, T., Lawson, J., Levesque, M., Lowenstein, M., Majjhoo, A., Mcarthur, R., McLain, D., Merrill, J., Murillo, A., Neucks, S., Niemer, G., Noaiseh, G., Parker, C., Pantojas, C., Pattanaik, D., Petri, M., Reveille, J., Roman-Miranda, A., Rothfield, N., Sankoorikal, A., Sayers, M., Singhal, A., Snyder, A., Striebich, C., Vo, Q., von Feldt, J., Wallace, D., Wasko, M., Young, C., Adelstein, S., Hall, S., Littlejohn, G., Nicholls, D., Suranyi, M., Amoura, Z., Bannert, B., Behrens, F., Perez, L. C., Chakravarty, K., Gonzales, F. D., Davies, K., Doria, A., Emery, P., Fernández-Nebro, A., Govoni, M., Hachulla, E., Hellmich, B., Houssiau, F., Malaise, M., Margaux, J., Maugars, Y., Muñoz-Fernández, S., Navarro, F., Ordi-Ros, J., Pellerito, R., Pena-Sagredo, J., Roussou, E., Schmidt, R. E., Ucar-Angulo, E., Viallard, J. F., Westhovens, R., Worm, M., Yee, C. S., Nayiager, S., Reuter, H., Spargo, C., Bazela, B., Brzosko, M., Chudzik, D., Gasztonyi, B., Geher, P., Ionescu, R., Jeka, S., Kemeny, L., Kiss, E., Kotyla, P., Kovacs, L., Kovalenko, V., Kucharz, E., Kwiatkowska, B., Leszczynski, P., Levchenko, E., Lysenko, G., Majdan, M., Mihailov, C., Nalotov, S., Nedelciu, M., Pavel, M., Raskina, T., Rebrov, B., Rezus, E., Semen, T., Smakotina, S., Stanislavchuk, M., Stanislav, M., Szombati, I., Szucs, G., Udrea, G., Zajdel, J., Zon-Giebel, A., Bonfiglioli, R., Bustamante, R., Klumb, E., Ramirez, G. M., Neiva, C., Olguin, M., Gonzaga, J. R., Scotton, A., Ayala, S. S., Ximenes, A., Sharma, R., Srikantiah, C., Aelion, J., Aranow, C., Baker, M., Chadha, A., Chao, J., Chatham, W., Chow, A., Clay, C., Cohen-Gadol, S., Conaway, D., Denburg, J., Escalante, A., Espinoza, L., Fiechtner, J., Fortin, I., Fraser, A., Furie, R., Gladman, D., Goddard, D., Goldberg, M., Gonzalez-Rivera, R., Gorman, J., Griffin, R., Haaland, D., Halter, D., Hemaiden, A., Hobbs, K., Joshi, V., Lim, S., Kalunian, K., Karpouzas, G., Khraishi, M., Lafyatis, R., Lee, S., Lidman, R., Lue, C., Mohan, M., Mease, P., Mehta, C., Mizutani, W., Nami, A., Nascimento, J., Neuwelt, C., Pappas, J., Pope, J., Porges, A., Roane, G., Rosenberg, D., Ross, S., Saadeh, C., Scoville, C., Sherrer, Y., Solomon, M., Surbeck, W., Valenzuela, G., Waller, P., Alten, R., Baerwald, C., Bienvenu, B., Bombardieri, S., Braun, J., Dival, L., Espinosa, G., Fernandez, I. F., Gomez-Reino, J., Gordon, C., Hiepe, F., Hopkinson, N., Isenberg, D., Jacobi, A., Jorgensen, C., Guern, V. L., Paul, C., Pego-Reigosa, J. M., Heredia, J. R., Rubbert-Roth, A., Sabbadini, M., Schroeder, J., Schwarting, A., Spieler, W., Valesini, G., Wollenhaupt, J., Mendoza, A. Z., Zouboulis, C. & on behalf of the EMBODY Investigator Group Feb 1 2017 In : Arthritis and Rheumatology. 69, 2, p. 362-375 14 p.

Research output: Contribution to journalArticle

Systemic Lupus Erythematosus
Safety
Placebos
B-Lymphocytes
Antinuclear Antibodies

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab

Hoffman, R. W., Merrill, J. T., Alarcón-Riquelme, M. M. E., Petri, M., Dow, E. R., Nantz, E., Nisenbaum, L. K., Schroeder, K. M., Komocsar, W. J., Perumal, N. B., Linnik, M. D., Airey, D. C., Liu, Y., Rocha, G. V. & Higgs, R. E. Mar 1 2017 In : Arthritis and Rheumatology. 69, 3, p. 643-654 12 p.

Research output: Contribution to journalArticle

Systemic Lupus Erythematosus
Gene Expression
Interferons
Genes
Gene Regulatory Networks